title: Tocilizumab for giant cell arteritis: an amazing result.
abstract: Giant cell arteritis (GCA), previously Horton's disease, is a systemic vasculitis affecting the middle-sized or large arteries in patients older than 50 years of age. The mainstay of the treatment of GCA is glucocorticoid therapy. Herein, we present a case with giant cell arteritis resistant to oral and intravenous steroid, intravenous cyclophosphamide and mycophenolate mofetil, but successfully treated with tocilizumab.
authors.affiliation: Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Sihhiye, 06100, Ankara, Turkey, metin1721978@yahoo.com.
authors.forename: Metin
authors.initials: M
authors.lastname: Işık
authors.forename: Levent
authors.initials: L
authors.lastname: Kılıç
authors.forename: İsmail
authors.initials: İ
authors.lastname: Doğan
authors.forename: Meral
authors.initials: M
authors.lastname: Calgüneri
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C502936:tocilizumab